시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
C 반응성 단백질 검사 시장 규모, 점유율, 성장 분석 : 어세이 유형별, 검출 범위별, 질병 영역별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)
C-Reactive Protein Testing Market Size, Share, Growth Analysis, By Assay Type (Immunoturbidimetric Assay, Elisa), By Detection Range (HS-CRP, Conventional CRP), By Disease Area, By End-Use, By Region - Industry Forecast 2024-2031
상품코드 : 1619137
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 260 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,590,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,879,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,168,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

C 반응성 단백질 검사 세계 시장 규모는 2022년 45억 달러로 평가되며, 2023년 46억 달러에서 2031년 55억 2,000만 달러로 예측 기간(2024-2031년) 동안 2.3%의 CAGR로 성장할 것으로 예상됩니다.

C 반응성 단백질 검사 세계 시장은 특이성, 민감도 및 신속한 현장 진단을 강화하는 나노기술의 발전으로 인해 큰 성장이 예상됩니다. 신속한 진단 도구에 대한 수요가 증가함에 따라 CRP 검사를 위한 새로운 현장 검사법이 등장하고 있으며, 모하메드 VI 대학의 연구는 SARS-CoV-2의 중증도 평가에 대한 CRP의 잠재력을 밝혀 CRP의 중요성을 더욱 부각시키고 있습니다. 또한, 염증성 질환, 당뇨병, 암의 유병률 증가, 자궁내막증 유병률 증가, 진단에 대한 자금 지원 증가는 시장 확대에 박차를 가할 것으로 예상되며, CDC 보고서에 따르면 미국에서 2,010만 명 이상의 성인이 관상동맥 질환을 앓고 있으며, 이 숫자는 계속 증가할 것으로 예상됩니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

C 반응성 단백질 검사 시장 규모 : 어세이 유형별

C 반응성 단백질 검사 시장 규모 : 검출 범위별

C 반응성 단백질 검사 시장 규모 : 질환 영역별

C 반응성 단백질 검사 시장 규모 : 최종 용도별

C 반응성 단백질 검사 시장 규모

경쟁 정보

주요 기업 개요

결론과 추천사항

ksm
영문 목차

영문목차

Global C-Reactive Protein Testing Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.6 billion in 2023 to USD 5.52 billion by 2031, growing at a CAGR of 2.3% during the forecast period (2024-2031).

The global market for C-reactive protein testing is poised for significant growth, driven by advancements in nanotechnology that enhance specificity, sensitivity, and rapid on-site disease diagnosis. New point-of-care assays for CRP testing are emerging, responding to the increasing demand for swift diagnostic tools. Research from Mohammed VI University highlights CRP's potential in assessing SARS-CoV-2 severity, further cementing its relevance. Additionally, the rising prevalence of inflammatory disorders, diabetes, and cancers, alongside a growing incidence of endometriosis and increased funding in diagnostics, is expected to fuel market expansion. Notably, the CDC reported that over 20.1 million adults in the U.S. suffer from coronary artery disease, a number anticipated to rise, thereby amplifying market opportunities in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global C-Reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global C-Reactive Protein Testing Market Segmental Analysis

Global C-Reactive Protein Testing Market is segmented by assay type, detection range, disease area, end-use and region. Based on assay type, the market is segmented into immunoturbidimetric assay, ELISA, chemiluminescence immunoassay and others. Based on detection range, the market is segmented into HS-CRP, conventional CRP and cCRP. Based on disease area, the market is segmented into cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus and others. Based on end-use, the market is segmented into clinics, hospitals, laboratories, assisted living healthcare facilities, home and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global C-Reactive Protein Testing Market

The global C-reactive protein testing market is poised for significant growth, primarily fueled by the increasing prevalence of cardiovascular diseases. With over 800,000 fatalities attributed to cardiovascular conditions annually in the United States alone, the demand for effective C-reactive protein testing methods is surging. Additionally, the ongoing research and development aimed at enhancing these testing methodologies will further propel market expansion. The combination of an ageing population and a rising incidence of diabetes mellitus also contributes to this upward trend, indicating a robust market potential in the foreseeable future as healthcare providers seek better diagnostic solutions.

Restraints in the Global C-Reactive Protein Testing Market

The global C-Reactive Protein Testing market is likely to face significant restraints primarily due to low awareness about CRP testing and the limited availability of advanced technologies in lower and medium-sized economies worldwide. This lack of knowledge can lead to underutilization of these important diagnostic tools, hindering market expansion. Furthermore, the high costs associated with CRP testing procedures and the substantial initial investments required to establish appropriate setups could further inhibit growth in the market. Together, these factors pose considerable challenges that may slow down the adoption and proliferation of C-reactive protein testing solutions globally during the forecast period.

Market Trends of the Global C-Reactive Protein Testing Market

The global C-Reactive Protein (CRP) testing market is experiencing significant growth, driven by heightened awareness programs and government initiatives aimed at educating the public on chronic disease prevention and treatment. This surge in awareness has led to the widespread integration of CRP testing in routine clinical practices, particularly in developed regions such as the United States, Germany, France, and Japan. As healthcare providers increasingly prioritize CRP tests for assessing inflammation and guiding treatment decisions, the market is poised for robust expansion in the coming years, reflecting a shift towards proactive health management and early disease detection.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global C-Reactive Protein Testing Market Size by Assay Type & CAGR (2024-2031)

Global C-Reactive Protein Testing Market Size by Detection Range & CAGR (2024-2031)

Global C-Reactive Protein Testing Market Size by Disease Area & CAGR (2024-2031)

Global C-Reactive Protein Testing Market Size by End-Use & CAGR (2024-2031)

Global C-Reactive Protein Testing Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기